1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United States Pharmaceuticals and Healthcare Report Q3 2016

United States Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 106 pages

Includes 3 FREE quarterly updates

BMI View: Health expenditure in the US is forecast to increase by more than 50% over the next decade. Acommon misconception is that drug companies and medicine price hikes are accountable for this rise andthe downward pressure it allegedly puts on prosperity. Latest data shows that healthcare accounts for17.5% of GDP in the world's largest economy, while in most other developed states this figure isapproximately 10%. In reality, expenditure on pharmaceuticals only accounts for a small component ofoverall health spending in the US, and that this proportion will actually decrease over the next 10 years.

Headline Expenditure Projections

- Pharmaceuticals: USD333bn in 2015 to USD348bn in 2016; +4.3% growth. Market forecastrevised downwards since Q216 due to consideration and incorporation of new macroeconomic data.

- Healthcare: USD3,139bn in 2015 to USD3,293bn in 2016; +4.9% growth. Forecast revised downwardssince Q216 due to consideration and incorporation of new macroeconomic data.

Table Of Contents

United States Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United States 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United States 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United States 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United States 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United States 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (United States 2014-2020) 29
Industry Risk Reward Index 30
Americas Risk/Reward Index 30
United States Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Intellectual Property Issues 52
Pricing and Reimbursement Regime 53
The November 2016 Presidential Election 55
Market Overview 57
Healthcare Sector 58
Table: Key Features Of The Affordable Care Act By Year 60
Table: Healthcare Resources (United States 2010-2015) 63
Table: Healthcare Personnel (United States 2010-2015) 63
Table: Healthcare Activity (United States 2010-2015) 64
Clinical Trials 64
Epidemiology 66
Competitive Landscape 69
Research-Based Industry 69
Table: Multinational Market Activity 69
Pharmaceutical Distribution 71
Pharmaceutical Retail Sector 71
Company Profile 72
Amgen 72
AstraZeneca 77
Eli Lilly 81
GlaxoSmithKline 84
Merck and Co 88
Pfizer 92
Demographic Forecast 95
Table: Population Headline Indicators (United States 1990-2025) 96
Table: Key Population Ratios (United States 1990-2025) 96
Table: Urban/Rural Population and Life Expectancy (United States 1990-2025) 97
Table: Population By Age Group (United States 1990-2025) 97
Table: Population By Age Group % (United States 1990-2025) 98
Glossary 100
Methodology 102
Pharmaceutical Expenditure Forecast Model 102
Healthcare Expenditure Forecast Model 102
Notes On Methodology 103
Risk/Reward Index Methodology 104
Index Overview 105
Table: Pharmaceutical Risk/Reward Index Indicators 105
Indicator Weightings 106

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.